Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 26Leukemia, Myeloid, Acute 24Lymphoma, Non-Hodgkin 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Hodgkin Disease 16Hematologic Neoplasms 16Lymphoma 14Leukemia, Lymphocytic, Chronic, B-Cell 14Multiple Myeloma 11Myeloproliferative Disorders 10Graft vs Host Disease 9Primary Myelofibrosis 8Leukemia, Myelomonocytic, Juvenile 8Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Neoplasms 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Accelerated Phase 5Burkitt Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Chronic-Phase 4Congenital Abnormalities 4Blast Crisis 4Waldenstrom Macroglobulinemia 3Neuroblastoma 3

Interventions

fludarabine phosphate 4Cyclophosphamide 4Busulfan 3Antilymphocyte Serum 3fludarabine 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2thymoglobulin 1sargramostim 1prexasertib 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1Quercetin 1Mycophenolic Acid 1Melphalan 1Dietary Supplements 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fanconi Anemia × thymoglobulin × Clear all
NCT02143830 2025-11-12

RAFA

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
70 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡